⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001860422

Karande Mahesh

Reports to the SEC for 1 company · CAMBRIDGE, MA

Transactions

7

Companies

1

Filings

5

CIK

0001860422

Forms 4 and 5

Insider transactions

7 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-07	Omega Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+210K sh	—	—	209,551
2024-02-07	Omega Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+314K sh	—	—	314,326
2023-02-28	Omega Therapeutics, Inc.Option (Right to Buy)A Award	Director, President and CEO	AAward	+170K sh	—	—	170,000
2022-10-27	Omega Therapeutics, Inc.Option (Right to Buy)A Award	Director, President and CEO	AAward	+170K sh	—	—	170,000
2022-03-09	Omega Therapeutics, Inc.Option (Right to Buy)A Award	Director, President and CEO	AAward	+340K sh	—	—	340,000
2022-02-01	Omega Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+11.3K sh	$0.53	+$5,989	117,711
2022-02-01	Omega Therapeutics, Inc.Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−11.3K sh	—	—	884,071

Recent filings

5

Accepted (ET)
Feb 94
Karande Mahesh0000950170-24-013364
SEC(opens sec.gov)
Mar 24
Karande Mahesh0000899243-23-006727
SEC(opens sec.gov)
Oct 284
Karande Mahesh0000899243-22-034472
SEC(opens sec.gov)
Mar 114
Karande Mahesh0000899243-22-010694
SEC(opens sec.gov)
Feb 34
Karande Mahesh0000899243-22-004562
SEC(opens sec.gov)

Companies

1

Omega Therapeutics, Inc.Director, President and CEO

Address

C/O OMEGA THERAPEUTICS, INC. 20 ACORN PARK DRIVE

CAMBRIDGE, MA, 02140